Evidence map›Paper›PMID 36741689›Full record

ArticleFrontiers in oncology2022

Folate receptor-positive circulating tumor cell count, lymphocyte count and derived neutrophil-to- lymphocyte ratio for diagnosing lung cancer relapse.

Huanrong Wang, Lei Liu, Jiaqin Yan, Wang Ma, Yabing Du, Tengfei Zhang

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Folate Receptor Alpha-A Novel Approach to Cancer Therapy.International journal of molecular sciences · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Huanrong WangDepartment of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Lei LiuDepartment of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Jiaqin YanDepartment of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Wang MaDepartment of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Yabing DuDepartment of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Tengfei ZhangDepartment of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
First Affiliated Hospital of Zhengzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The folate receptor-positive circulating tumor cell (FR

Indexed as

derived neutrophil-to-lymphocyte ratiofirst-line treatmentfolate receptor-positive circulating tumor celllung cancerlymphopeniaprognosisrelapse

Identifiers

PMID36741689
PMCPMC9893416
OpenAlexW4317423503

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.